Firm-Wide blog

FDA Issues Warning that the Antibiotic Tygacil Increases the Risk of Death

By Burg Simpson
September 27, 2013
1 min read

The FDA recently warned that Tygacil (tigecycline) increases the risk of death in patients compared to other antibiotics.  Tygacil is an injectable prescription drug that treats complex bacterial infections, such as skin infections or pneumonia.  Pfizer manufactures Tygacil, which the FDA approved in 2005.

On September 27, 2013, the FDA warned that patients using Tygacil are at an increased risk of dying from worsening infections, complications of infection, or other underlying medical conditions.

FDA Safety Alert

The FDA cautioned that 2.5% of Tygacil patients died, compared to 1.8% of patients on other antibiotics.  Accordingly, the  FDA will add its harshest warning, a Black Box Warning, to Tygacil’s label.  The Black Box Warning advises that Tygacil should only be used “when alternative treatments are not suitable.”

If you or a loved one suffered injuries that you believe were caused by Tygacil, contact one of the experienced dangerous drug attorneys at Burg Simpson today.  Our award-winning lawyers would be happy to discuss your potential claim. Call 1-800-713-9340 or fill out our contact form for a FREE no-obligation consultation today.


Free case evaluation form